Wademan, D T <br/><br/>
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  12 2019 
 - 1263-1268 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.19.0115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Antitubercular Agents--administration & dosage<br/>Case-Control Studies<br/>Child<br/>Child Health Services<br/>Child, Preschool<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Interviews as Topic<br/>Male<br/>Patient Satisfaction<br/>South Africa<br/>Tuberculosis, Pulmonary--drug therapy